VistaGen Therapeutics, Inc.
VTGN · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$51,418 | -$29,362 | -$59,248 | -$47,762 |
| Dep. & Amort. | $635 | $568 | $532 | $711 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4,315 | $2,182 | $3,336 | $3,481 |
| Change in WC | $4,760 | $793 | $2,027 | -$1,918 |
| Other Non-Cash | -$389 | $6 | $3,637 | $232 |
| Operating Cash Flow | -$42,097 | -$25,813 | -$49,716 | -$45,257 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$191 | -$61 | -$212 | -$200 |
| Net Acquisitions | $0 | $0 | -$528 | $0 |
| Inv. Purchases | -$24,984 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $12,027 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$13,148 | -$61 | -$740 | -$200 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$985 | -$1,034 | -$3 |
| Stock Issued | $3,009 | $129,379 | $104 | $4,439 |
| Stock Repurch. | $0 | $0 | -$174 | $0 |
| Dividends Paid | $0 | $0 | $0 | -$945,100 |
| Other Fin. Act. | $201 | $8 | $63 | $951,148 |
| Financing Cash Flow | $3,210 | $128,402 | -$1,041 | $10,484 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$52,035 | $102,528 | -$51,497 | -$34,973 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $119,166 | $16,638 | $68,135 | $103,108 |
| End Cash | $67,131 | $119,166 | $16,638 | $68,135 |
| Free Cash Flow | -$42,288 | -$25,874 | -$49,928 | -$45,457 |